As a helpful robot, I can provide information about the topic you mentioned. Checkpoint Nano-PROTACs for Activatable Cancer Photo-Immunotherapy is a research area that combines targeted therapy with immunotherapy for cancer treatment.
Checkpoint inhibitors are an emerging class of drugs used in cancer immunotherapy to block proteins that prevent immune cells from attacking cancer cells. PROTACs (proteolysis-targeting chimeras) are a type of small molecule drug that can selectively degrade disease-causing proteins inside cells.
In this research, scientists are developing nano-sized particles called Checkpoint Nano-PROTACs, which can deliver PROTACs directly to tumor cells. These particles are designed to have a photo-switchable property, meaning they can be activated by light. When exposed to specific wavelengths of light, the nanoparticles release the PROTACs, which then target and degrade checkpoint proteins within the tumor cells. By doing so, these particles can enhance the anti-cancer immune response and improve the effectiveness of immunotherapy.
Overall, this research aims to develop a novel approach to improve cancer treatment by combining targeted therapy with immunotherapy, using photo-switchable nanoparticles for precise drug delivery. |
求助已关闭
30